{"a":[{"_":"Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal","$":{"href":"/biotech/pfizer-offloads-scrapped-seagen-adc-medicus-pharma-1b-deal","hreflang":"en"}}]}

Summary

Pfizer has divested an antibody-drug conjugate acquired from its $43 billion Seagen acquisition to Medicus Pharma in a deal valued up to $1 billion or more. The asset was previously dropped by Pfizer earlier in 2026.